Open Access
Issue
BIO Web Conf.
Volume 214, 2026
The 2025 International Conference on Biomedical, Bioinformatics and Statistics (ICBBS 2025)
Article Number 01009
Number of page(s) 5
Section Biomedical, Bioinformatics and Statistics
DOI https://doi.org/10.1051/bioconf/202621401009
Published online 02 February 2026
  • F. Bray, M. Laversanne, H. Sung, J. Ferlay, R.L. Siegel, I. Soerjomataram, A. Jemal, Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer. J. Clin. 74, 229–263 (2024 May-Jun) [Google Scholar]
  • S.V. Hato, A. Khong, I.J.M. de Vries, W.J. Lesterhuis, Molecular pathways: the immunogenic effects of platinum-based chemotherapeutics. Clin. Cancer Res. 20, 2831–2837 (2014) [Google Scholar]
  • P. Kumar, P.N. Navya, A. Begum, R. Ojha, M. Plebanski, S.K. Bhargava, Unveiling the anticancer potential of gold-sulfur complexes: mechanisms, delivery strategies, and clinical progression. Coordin. Chem. Rev. 541, 216809 (2025) [Google Scholar]
  • M. Salmain, B. Bertrand, Emerging anticancer therapeutic modalities brought by gold complexes: overview and perspectives. Eur. J. Inorg. Chem. 26, e202300340 (2023) [Google Scholar]
  • X. Hu, The synthesis, characterization and biological activity research of gold complexes, Master Thesis, University of Electronic Science and Technology of China (2014) [Google Scholar]
  • J.L. Hickey, R.A. Ruhayel, P.J. Barnard, M.V. Baker, S.J. Berners-Price, A. Filipovska, Mitochondria-targeted chemotherapeutics: the rational design of gold(i) n-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols. J. Am. Chem. Soc. 130, 12570–12571 (2008) [Google Scholar]
  • C.M. Gallati, S.K. Goetzfried, A. Ortmeier, J. Sagasser, K. Wurst, M. Hermann, D. Baecker, B. Kircher, R. Gust, Synthesis, characterization and biological activity of bis[3-ethyl-4-aryl-5-(2-methoxypyridin-5-yl)-l-propyl-1,3-dihydro-2H-imidazol-2-ylidene]gold(I) complexes. Dalton Trans. 50, 4270 (2021) [Google Scholar]
  • M. Marra, A. Mariconda, D. Iacopetta, J. Ceramella, A. D'Amato, C. Rosano; K. Tkachenko, M. Pellegrino, S. Aquaro, M.S. Sinicropi, et al. When chirality makes the difference: the case of novel enantiopure n-heterocyclic carbene-gold and -silver complexes. Molecules 29, 5262 (2024) [Google Scholar]
  • H.S. Al-Buthabhak, V. Falasca, Y. Yu, A.N. Sobolev, B.W. Skelton, S.A. Moggach, V. Ferro, H. Al-Salami, M.V. Baker, Au-NHC complexes with thiocarboxylate ligands: synthesis, structure, stability, thiol exchange and in vitro anticancer activity. Appl. Organometal. Chem. 38, e6645 (2024) [Google Scholar]
  • X. Ma, Y. Zhao, I. Caligiuri, F. Rizzolio, N.B. Pozsoni, K. Van Hecke, T. Scattolin, S. P. Nolan, Dinuclear NHC-gold(I)-thiolato and - alkynyl complexes: synthesis, anticancer activity, and catalytic activity in lactonization reactions. Dalton Trans. 53, 7939 (2024) [Google Scholar]
  • B. Bertrand, A. S. Romanov, M. Brooks, J. Davis, C. Schmidt, I. Ott, M. O'Connell, M. Bochmann, Synthesis, structure and cytotoxicity of cyclic (alkyl)(amino) carbene and acyclic carbene complexes of group 11 metals. Dalton Trans. 46, 15875 (2017) [Google Scholar]
  • M. T. Proetto, K. Alexander, M. Melaimi, G. Bertrand, N. C. Gianneschi, Cyclic (alkyl)(amino)carbene (CAAC) gold(I) complexes as chemotherapeutic agents. Chem. Eur. J. 27, 3772 (2021) [Google Scholar]
  • J. Zhang, M. A. Abu el Maaty, H. Hoffmeister, C. Schmidt, J. K. Muenzner, R. Schobert, S. Wölfl, I. Ott, A multitarget, gold(I) complex induces cytotoxicity related to aneuploidy in hct-116 colorectal carcinoma cells. Angew. Chem. Int. Ed. 59, 16795 (2020) [Google Scholar]
  • G. Canudo-Barreras, L. Ortego, A. Izaga, I. Marzo, R.P. Herrera, M.C Gimeno, Synthesis of new thiourea-metal complexes with promising anticancer properties. Molecules 26, 6891 (2021) [Google Scholar]
  • M. Luo, X. Ma, W. Jiang, J. Zhang, W. Liu, S. Wei, H. Liu, Novel phosphanegold(I) thiolate complexes suppress de novo lipid synthesis in human lung cancer. Eur. J. Med. Chem. 232, 114168 (2022) [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.